Class information for:
Level 1: MYELODYSPLASTIC SYNDROME//AZACITIDINE//MDS

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
1137 2828 41.0 87%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
51 3       HEMATOLOGY//BONE MARROW TRANSPLANTATION//BLOOD 91443
56 2             MYELODYSPLASTIC SYNDROME//HEMATOLOGY//ACUTE MYELOID LEUKEMIA 29625
1137 1                   MYELODYSPLASTIC SYNDROME//AZACITIDINE//MDS 2828

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 MYELODYSPLASTIC SYNDROME authKW 4733225 43% 36% 1217
2 AZACITIDINE authKW 1082920 6% 63% 159
3 MDS authKW 1006157 10% 33% 283
4 HYPOMETHYLATING AGENTS authKW 470679 3% 58% 75
5 DEL5Q authKW 354284 1% 86% 38
6 DECITABINE authKW 305816 3% 29% 97
7 CHRONIC MYELOMONOCYTIC LEUKEMIA authKW 292498 3% 38% 71
8 HEMATOL ONCOL CLIN IMMUNOL address 290521 3% 35% 78
9 INTERNATIONAL PROGNOSTIC SCORING SYSTEM authKW 286731 1% 80% 33
10 5Q SYNDROME authKW 201501 1% 67% 28

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Hematology 130937 65% 1% 1839
2 Oncology 20189 44% 0% 1243
3 Pathology 362 4% 0% 110
4 Transplantation 333 3% 0% 75
5 Medical Laboratory Technology 281 2% 0% 54
6 Medicine, Research & Experimental 215 4% 0% 126
7 Medicine, General & Internal 88 4% 0% 124
8 Genetics & Heredity 69 4% 0% 101
9 Cell & Tissue Engineering 38 0% 0% 12
10 Education, Scientific Disciplines 36 1% 0% 22

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 HEMATOL ONCOL CLIN IMMUNOL 290521 3% 35% 78
2 LEUKEMIA PROGRAM 197804 2% 37% 49
3 MALIGNANT HEMATOL 143188 2% 26% 51
4 HEMATOL ONCOL BLOOD DISORDERS 140944 2% 25% 52
5 TRANSLAT HEMATOL ONCOL 122013 1% 27% 42
6 HEMATOL 119587 26% 2% 738
7 LEUKEMIA 99351 5% 6% 150
8 LLR MOL HAEMATOL UNIT 93301 0% 79% 11
9 RUSH CANC 85629 1% 36% 22
10 SERV HEMATOL SENIORS 76767 0% 89% 8

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 LEUKEMIA RESEARCH 190096 12% 5% 326
2 LEUKEMIA 36952 6% 2% 161
3 CURRENT HEMATOLOGIC MALIGNANCY REPORTS 30988 1% 10% 30
4 BRITISH JOURNAL OF HAEMATOLOGY 20105 6% 1% 159
5 ANNALS OF HEMATOLOGY 19205 3% 2% 81
6 HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 14751 2% 3% 49
7 BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY 13966 1% 4% 33
8 BLOOD 13921 7% 1% 212
9 CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 13574 1% 4% 31
10 LEUKEMIA & LYMPHOMA 13256 3% 1% 97

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class		 LCSH search Wikipedia search
1 MYELODYSPLASTIC SYNDROME 4733225 43% 36% 1217 Search MYELODYSPLASTIC+SYNDROME Search MYELODYSPLASTIC+SYNDROME
2 AZACITIDINE 1082920 6% 63% 159 Search AZACITIDINE Search AZACITIDINE
3 MDS 1006157 10% 33% 283 Search MDS Search MDS
4 HYPOMETHYLATING AGENTS 470679 3% 58% 75 Search HYPOMETHYLATING+AGENTS Search HYPOMETHYLATING+AGENTS
5 DEL5Q 354284 1% 86% 38 Search DEL5Q Search DEL5Q
6 DECITABINE 305816 3% 29% 97 Search DECITABINE Search DECITABINE
7 CHRONIC MYELOMONOCYTIC LEUKEMIA 292498 3% 38% 71 Search CHRONIC+MYELOMONOCYTIC+LEUKEMIA Search CHRONIC+MYELOMONOCYTIC+LEUKEMIA
8 INTERNATIONAL PROGNOSTIC SCORING SYSTEM 286731 1% 80% 33 Search INTERNATIONAL+PROGNOSTIC+SCORING+SYSTEM Search INTERNATIONAL+PROGNOSTIC+SCORING+SYSTEM
9 5Q SYNDROME 201501 1% 67% 28 Search 5Q+SYNDROME Search 5Q+SYNDROME
10 MYELODYSPLASTIC SYNDROMES MDS 191900 1% 48% 37 Search MYELODYSPLASTIC+SYNDROMES+MDS Search MYELODYSPLASTIC+SYNDROMES+MDS

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 MALCOVATI, L , HELLSTROM-LINDBERG, E , BOWEN, D , ADES, L , CERMAK, J , DEL CANIZO, C , DELLA PORTA, MG , FENAUX, P , GATTERMANN, N , GERMING, U , ET AL (2013) DIAGNOSIS AND TREATMENT OF PRIMARY MYELODYSPLASTIC SYNDROMES IN ADULTS: RECOMMENDATIONS FROM THE EUROPEAN LEUKEMIANET.BLOOD. VOL. 122. ISSUE 17. P. 2943-2964 155 62% 100
2 ZEIDAN, AM , LINHARES, Y , GORE, SD , (2013) CURRENT THERAPY OF MYELODYSPLASTIC SYNDROMES.BLOOD REVIEWS. VOL. 27. ISSUE 5. P. 243-259 152 81% 17
3 ADES, L , ITZYKSON, R , FENAUX, P , (2014) MYELODYSPLASTIC SYNDROMES.LANCET. VOL. 383. ISSUE 9936. P. 2239 -2252 108 74% 50
4 GREENBERG, PL , STONE, RM , AL-KALI, A , BARTA, SK , BEJAR, R , BENNETT, JM , CARRAWAY, H , DE CASTRO, CM , DEEG, HJ , DEZERN, AE , ET AL (2017) MYELODYSPLASTIC SYNDROMES, VERSION 2.2017 CLINICAL PRACTICE GUIDELINES IN ONCOLOGY.JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. VOL. 15. ISSUE 1. P. 60 -87 115 80% 0
5 GORE, SD , ZEIDAN, AM , LEE, EJ , PODOLTSEV, N , (2016) THE EVOLVING FIELD OF PROGNOSTICATION AND RISK STRATIFICATION IN MDS: RECENT DEVELOPMENTS AND FUTURE DIRECTIONS.BLOOD REVIEWS. VOL. 30. ISSUE 1. P. 1 -10 98 94% 0
6 BEJAR, R , STEENSMA, DP , (2014) RECENT DEVELOPMENTS IN MYELODYSPLASTIC SYNDROMES.BLOOD. VOL. 124. ISSUE 18. P. 2793 -2803 87 75% 38
7 DUONG, VH , KOMROKJI, RS , LIST, AF , (2014) UPDATE ON THE PHARMACOTHERAPY FOR MYELODYSPLASTIC SYNDROMES.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 15. ISSUE 13. P. 1811 -1825 99 85% 2
8 ZEIDAN, AM , GORE, SD , PADRON, E , KOMROKJI, RS , (2015) CURRENT STATE OF PROGNOSTICATION AND RISK STRATIFICATION IN MYELODYSPLASTIC SYNDROMES.CURRENT OPINION IN HEMATOLOGY. VOL. 22. ISSUE 2. P. 146 -154 74 96% 4
9 GREENBERG, PL , ATTAR, E , BENNETT, JM , BLOOMFIELD, CD , BORATE, U , DE CASTRO, CM , DEEG, HJ , FRANKFURT, O , GAENSLER, K , GARCIA-MANERO, G , ET AL (2013) MYELODYSPLASTIC SYNDROMES.JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. VOL. 11. ISSUE 7. P. 838 -874 99 66% 33
10 ZEIDAN, AM , STAHL, M , KOMROKJI, R , (2016) EMERGING BIOLOGICAL THERAPIES FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES.EXPERT OPINION ON EMERGING DRUGS. VOL. 21. ISSUE 3. P. 283 -300 117 59% 0

Classes with closest relation at Level 1


Rank Class id link
1 3781 MYELODYSPLASTIC SYNDROME//CANCER GENETICS AND CYTOGENETICS//MYELODYSPLASIA
2 27397 DEL20Q//IDER20Q//TETRASOMY 8
3 17423 JUVENILE MYELOMONOCYTIC LEUKEMIA//JMML//JUVENILE MYELOMONOCYTIC LEUKAEMIA
4 28007 ACUTE ERYTHROLEUKEMIA//PURE ERYTHROID LEUKEMIA//ACUTE ERYTHROID LEUKEMIA
5 552 ACUTE MYELOID LEUKEMIA//FLT3//FLT3 ITD
6 5355 DECITABINE//5 AZA 2 DEOXYCYTIDINE//ZEBULARINE
7 30236 HERBOXIDIENE//SPLICEOSTATIN A//FR901464
8 8127 SECONDARY LEUKEMIA//THERAPY RELATED//THERAPY RELATED LEUKEMIA
9 17196 PALMAR FASCIITIS//PARANEOPLASTIC VASCULITIS//LEUKEMIC ARTHRITIS
10 37469 AML CELL DEATH//ARSENIC TRIOXIDE 1//ATPASE BINDING CASSETTE ABC TRANSPORTERS

Go to start page